Literature DB >> 12560398

Mitochondrial disruption and apoptosis in lymphocytes of an HIV infected patient affected by lactic acidosis after treatment with highly active antiretroviral therapy.

M Tolomeo1, S Mancuso, M Todaro, G Stassi, M Catalano, S Arista, G Cannizzo, E Barbusca, V Abbadessa.   

Abstract

AIMS: Highly active antiretroviral therapy (HAART) can induce an increase in lactic acid concentrations that seems to be caused by mitochondrial dysfunction induced by the interaction of nucleoside reverse transcriptase inhibitors (NRTIs) with DNA polymerase gamma in the mitochondria. Mitochondrial alterations have been described in liver and muscle cells of NRTI treated human immunodeficiency virus (HIV) infected patients. Because lymphocytes are the main target for HIV and because mitochondria are involved in apoptosis, we studied mitochondrial morphology and apoptosis in the lymphocytes of an HIV infected patient with severe lactic acidosis after treatment with stavudine, didanosine, and indinavir.
METHODS: The patient was a 39 year old woman. After two years of treatment she developed rapid weight loss with severe fat wasting, peripheral neuropathy, and hyperlacticaemia, which persisted after treatment withdrawal. The numbers and the morphology of the mitochondria were evaluated by electronic microscopy; the percentage of apoptotic cells was calculated by flow cytometry after staining with annexine V and by fluorescent microscopy after staining with ethidium bromide and acridine orange.
RESULTS: The numbers of mitochondria in the lymphocytes were greatly decreased when compared with the lymphocytes of healthy individuals. The most important mitochondrial morphological alterations were swelling and the disruption of cristae and internal mitochondrial structure. These alterations were more evident during the period in which lactic acid values were very high. Moreover, a high percentage of apoptotic lymphocytes was seen. Morphological examination conducted one week after the normalisation of lacticaemia showed a pronounced increase in the number of mitochondria. The morphological alterations were no longer evident, although the size of each mitochondrion was smaller than normal. Moreover, the percentage of apoptotic cells was lower than 5%.
CONCLUSIONS: This report describes important morphological alterations in lymphocyte mitochondria in an HIV infected patient during a severe phase of HAART induced hyperlacticaemia. These alterations persisted for several weeks after treatment withdrawal and were associated with an increase in lymphocyte apoptosis. Considering the important role of mitochondria in the apoptotic pathway, the increase in lymphocyte apoptosis may be a consequence of proapoptotic factors released from altered mitochondria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560398      PMCID: PMC1769889          DOI: 10.1136/jcp.56.2.147

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

Review 1.  Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature.

Authors:  K Sundar; M Suarez; P E Banogon; J M Shapiro
Journal:  Crit Care Med       Date:  1997-08       Impact factor: 7.598

2.  AZT incorporation into mitochondria: study in a human myeloid cell line.

Authors:  N J Nusbaum; P E Joseph
Journal:  DNA Cell Biol       Date:  1996-05       Impact factor: 3.311

Review 3.  Mitochondrial toxicity of antiviral drugs.

Authors:  W Lewis; M C Dalakas
Journal:  Nat Med       Date:  1995-05       Impact factor: 53.440

4.  Lactic acidosis and acquired immunodeficiency syndrome.

Authors:  M Odeh
Journal:  J Intern Med       Date:  1994-10       Impact factor: 8.989

5.  Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.

Authors:  E M Sloand; N S Young; P Kumar; F F Weichold; T Sato; J P Maciejewski
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

Review 6.  Programmed cell death in HIV infection: dysregulation of BCL-2 and Fas pathways and contribution to AIDS pathogenesis.

Authors:  M L Gougeon
Journal:  Psychoneuroendocrinology       Date:  1997       Impact factor: 4.905

7.  Cardiac mitochondrial DNA polymerase-gamma is inhibited competitively and noncompetitively by phosphorylated zidovudine.

Authors:  W Lewis; J F Simpson; R R Meyer
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

Review 8.  Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS.

Authors:  J Dhein; H Walczak; M O Westendorp; C Bäumler; K Stricker; R Frank; K M Debatin; P H Krammer
Journal:  Behring Inst Mitt       Date:  1995-06

9.  Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy.

Authors:  I S Fortgang; P C Belitsos; R E Chaisson; R D Moore
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

10.  Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers.

Authors:  A Macho; M Castedo; P Marchetti; J J Aguilar; D Decaudin; N Zamzami; P M Girard; J Uriel; G Kroemer
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.